Stem cell-like ALDHbrightcellular states in EGFR-mutant non-small cell lung cancer: A novel mechanism of acquired resistance to erlotinib targetable with the natural polyphenol silibinin-Reference-Cited by-同舟云学术

Stem cell-like ALDHbrightcellular states in EGFR-mutant non-small cell lung cancer: A novel mechanism of acquired resistance to erlotinib targetable with the natural polyphenol silibinin

Published:2013-09-17 Issue:21 Volume:12 Page:3390-3404
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

COROMINAS-FAJA BRUNA,Oliveras-Ferraros Cristina,CUYÀS ELISABET,Segura-Carretero Antonio,Joven Jorge,Martin-Castillo Begoña,BARRAJÓN-CATALÁN ENRIQUE,Micol Vicente,Bosch-Barrera Joaquim,MENENDEZ MENENDEZ JAVIERABEL

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

http://www.tandfonline.com/doi/pdf/10.4161/cc.26417

Reference74 articles.

1. Second-line treatment of non-small-cell lung cancer: chemotherapy or tyrosine kinase inhibitors?;Passaro;Expert Rev Anticancer Ther,2011

2. Phase III trial of vandetanib compared with erlotinib in patients with previously treated advanced non-small-cell lung cancer;Natale;J Clin Oncol,2011

3. Erlotinib in previously treated non-small-cell lung cancer;Shepherd;N Engl J Med,2005

4. Efficacy and safety of erlotinib versus chemotherapy in second-line treatment of patients with advanced, non-small-cell lung cancer with poor prognosis (TITAN): a randomised multicentre, open-label, phase 3 study;Ciuleanu;Lancet Oncol,2012

5. Erlotinib and pemetrexed as maintenance therapy for advanced non-small-cell lung cancer: a systematic review and indirect comparison;Qi;Curr Med Res Opin,2012

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer stem cells: advances in knowledge and implications for cancer therapy;Signal Transduction and Targeted Therapy;2024-07-05

2. Promising Combinatorial Therapeutic Strategies against Non-Small Cell Lung Cancer;Cancers;2024-06-12

3. A comprehensive review on the use of traditional Chinese medicine for cancer treatment;Pharmacological Research - Modern Chinese Medicine;2024-06

4. The importance of integrated therapies on cancer: Silibinin, an old and new molecule;Oncotarget;2024-05-23

5. Effect of Plant Secondary Metabolites against Lung Cancer: A Comprehensive Review on Apoptosis Induction and Synergistic Potential;The Natural Products Journal;2024-04-15